Skip to content

Drug interactions

Posaconazole + Repotrectinib

Severity: Major

Posaconazole and Repotrectinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Repotrectinib is metabolized by CYP3A4 and is a P-gp substrate, so posaconazole can markedly raise its exposure. This may worsen neurologic effects such as dizziness and ataxia, along with other toxicity.

What this interaction means in plain words

Posaconazole and Repotrectinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Posaconazole belongs to Anti Fungals; Repotrectinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Posaconazole inhibits CYP3A4 and P-glycoprotein, reducing repotrectinib clearance.

What to do

Avoid concomitant use with strong CYP3A and P-gp inhibitors. Choose an alternative antifungal.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Posaconazole and Repotrectinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Posaconazole with Repotrectinib?

MediHelp rates the interaction as major. Posaconazole and Repotrectinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Repotrectinib is metabolized by CYP3A4 and is a P-gp substrate, so posaconazole can markedly raise its exposure. This may worsen neurologic effects such as dizziness and ataxia, along with other toxicity.

How serious is the interaction between Posaconazole and Repotrectinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concomitant use with strong CYP3A and P-gp inhibitors. Choose an alternative antifungal.

What other medicines interact with Posaconazole?

MediHelp also lists interactions of Posaconazole with, for example, Artemether, Avanafil, Cobimetinib. The full list is on the Posaconazole page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in